施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMY 施贵宝

休市中 05-03 16:00:00 EDT

43.99

+0.29

+0.66%

盘后43.99

+0.000.00%

19:59 EDT

最高44.33	最低43.69	成交量1,210万
今开43.90	昨收43.70	日振幅1.48%
总市值891.72亿	流通市值889.91亿	总股本20.27亿
成交额5.32亿	换手率0.60%	流通股本20.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":43.99,"timestamp":1714766400000,"preClose":43.7,"halted":0,"volume":12104488,"hourTrading":{"tag":"盘后","latestPrice":43.99,"preClose":43.99,"latestTime":"19:59 EDT","volume":335294,"amount":14749442.6582,"timestamp":1714780770547},"delay":0,"floatShares":2022972717,"shares":2027100096,"eps":-3.002585,"marketStatus":"休市中","marketStatusCode":7,"change":0.29,"latestTime":"05-03 16:00:00 EDT","open":43.9,"high":44.33,"low":43.685,"amount":532079339.39116,"amplitude":0.01476,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.002585,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":-18475200000,"adjPreClose":43.7,"adrRate":0,"dividendRate":0.053194,"preHourTrading":{"tag":"盘前","latestPrice":43.92,"preClose":43.7,"latestTime":"09:29 EDT","volume":17041,"amount":747729.121922,"timestamp":1714742998537},"postHourTrading":{"tag":"盘后","latestPrice":43.99,"preClose":43.99,"latestTime":"19:59 EDT","volume":335294,"amount":14749442.6582,"timestamp":1714780770547},"volumeRatio":0.7150838382827106},"requestUrl":"/m/hq/s/BMY/","defaultTab":"news","newsList":[{"id":"2431369005","title":"日本小野制药公司称 24 亿美元收购 Deciphera 是全球扩张的 \"第一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2431369005","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431369005?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:41","pubTimestamp":1714462881,"startTime":"0","endTime":"0","summary":" Rocky Swift    路透东京4月30日 - 日本小野制药公司  周二表示，它以24亿美元收购Deciphera Pharmaceuticals  是拓展美国和欧洲市场的 \"第一步\"。该药预计将从 2028 年起在主要市场失去专利保护。此次收购包括Deciphera公司用于治疗一种胃肠道癌症的口服药物Qinlock，该药于2020年获得美国食品和药物管理局的全面批准。数字Ono Pharma 的现金收购价为每股 25.60 美元，比总部位于美国的 Deciphera 之前的收盘价溢价 74.7%。Deciphera股价则大涨73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431510603","title":"全球首创心肌肌球蛋白抑制剂迈凡妥®（玛伐凯泰胶囊）在中国获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2431510603","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2431510603?lang=zh_cn&edition=full","pubTime":"2024-04-30 14:04","pubTimestamp":1714457040,"startTime":"0","endTime":"0","summary":"作为全球首创的心肌肌球蛋白抑制剂，迈凡妥可靶向疾病核心病理生理机制，通过与心肌肌球蛋白的可逆性结合，减少肌球蛋白和肌动蛋白横桥的数量，以减轻心肌的过度收缩，并改善舒张功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4401067_ZH01067_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431062308","title":"Repertoire与百时美施贵宝合作开发3款自免疫苗-36氪","url":"https://stock-news.laohu8.com/highlight/detail?id=2431062308","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431062308?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:00","pubTimestamp":1714438815,"startTime":"0","endTime":"0","summary":"4月29日，率先发现和开发可编程T细胞靶向免疫药物的生物技术公司Repertoire Immune Medicines宣布与百时美施贵宝达成合作协议，开发针对3种自免疾病的“耐受疫苗”，该合作旨在通过重置免疫系统，为患有自身免疫疾病的患者开发有效、选择性和持久的治疗方法。根据协议条款，Repertoire将获得6500万美元的预付款，以及高达18亿美元的预付款，用于实现开发、监管和商业里程碑，此外还将获得分级特许权使用费。（智通财经）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009001887c17471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009001887c17471&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431570758","title":"Repertoire与百时美施贵宝(BMY.US)合作开发3款自免疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2431570758","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2431570758?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:07","pubTimestamp":1714396064,"startTime":"0","endTime":"0","summary":"Repertoire与施贵宝(BMY.US)合作开发3款自免疫苗。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20240429/20240429210359_68247.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240429/20240429210359_68247.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115059.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430730380","title":"施贵宝2024财年第一财季实现净利润-119.11亿美元，同比减少626.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430730380","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430730380?lang=zh_cn&edition=full","pubTime":"2024-04-27 06:25","pubTimestamp":1714170303,"startTime":"0","endTime":"0","summary":"3月31日，施贵宝公布财报，公告显示公司2024财年第一财季净利润为-119.11亿美元，同比减少626.57%；其中营业收入为118.65亿美元，同比增加4.66%，每股基本收益为-5.89美元。机构评级：截至2024年3月31日，当前有22家机构对施贵宝目标价做出预测，其中目标均价为53.61美元，其中最低目标价为37.00美元，最高目标价为75.00美元。百时美施贵宝的一个重点是免疫肿瘤学，该公司是药物开发的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270625148b58a652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270625148b58a652&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430201385","title":"百时美施贵宝上涨1.21%，报45.24美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430201385","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430201385?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:02","pubTimestamp":1714143743,"startTime":"0","endTime":"0","summary":"4月26日，百时美施贵宝(BMY)盘中上涨1.21%，截至23:02，报45.24美元/股，成交2.04亿美元。财务数据显示，截至2024年03月31日，百时美施贵宝收入总额118.65亿美元，同比增长4.66%；归母净利润-119.11亿美元，同比减少626.57%。大事提醒：4月25日，百时美施贵宝2024财年一季报归属股东应占溢利-119.1亿美元，同比下降626.57%，基本每股收益-5.89美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/26230240441298.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430325638","title":"更新 1-标普 500 第一季度盈利前景本周有所改善 -LSEG","url":"https://stock-news.laohu8.com/highlight/detail?id=2430325638","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430325638?lang=zh_cn&edition=full","pubTime":"2024-04-26 03:45","pubTimestamp":1714074330,"startTime":"0","endTime":"0","summary":"LSEG周四的数据显示 ， 标普500指数2024年第一季度的同比盈利增长率目前 为4.3%。这一数字高于 前一天的 3.3%。最新的估计是基于标准普尔500   指数中190家公司的业绩和对其他公司的预测，其中约78%的报告超过了分析师的盈利预期。根据LSEG的估计，如果没有这项一次性支出，标准普尔500指数的收益预计将同比增长7.4%。然而，尽管季度盈利前景有所改善，但周四股市仍出现下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430232344","title":"施贵宝2023财年实现净利润80.25亿美元，同比增加26.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430232344","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430232344?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:23","pubTimestamp":1714065803,"startTime":"0","endTime":"0","summary":"12月31日，施贵宝公布财报，公告显示公司2023财年净利润为80.25亿美元，同比增加26.84%；其中营业收入为450.06亿美元，同比减少2.50%，每股基本收益为3.88美元。机构评级：截至2023年12月31日，当前有23家机构对施贵宝目标价做出预测，其中目标均价为55.70美元，其中最低目标价为40.00美元，最高目标价为75.00美元。百时美施贵宝近70%的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042601233087b01c9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042601233087b01c9c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"1128992656","title":"施贵宝一季度销售额118.65亿美元，同比增4.66%，高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1128992656","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/1128992656?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:31","pubTimestamp":1714055519,"startTime":"0","endTime":"0","summary":"每股亏损为4.40美元，上年同期每股收益2.05美元，同比下降了314.63%。","market":"us","thumbnail":"https://static.tigerbbs.com/6d47bcbbea437d87e2dd64ff70026292","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6d47bcbbea437d87e2dd64ff70026292"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1110516.html","is_publish_highlight":true,"gpt_icon":1},{"id":"2430281778","title":"施贵宝(BMY)跌逾7% 一季度盈转亏 大幅下调今年盈利预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281778","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2430281778?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:05","pubTimestamp":1714053912,"startTime":"0","endTime":"0","summary":"金吾财讯 | 施贵宝(BMY)跌7.03%，报45.44美元，成交额3.11亿美元。施贵宝公布2024年第一季度业绩，销售额为118.65亿美元，同比增长4.66%，市场预期为114.58亿美元；每股亏损为4.40美元，较上年同期的每股盈利2.05美元由盈转亏，市场预期为每股亏损4.44美元。因收购事项影响，施贵宝下调今年盈利预期，该公司预计全年调整后的每股收益在0.40美元至0.70美元之间，远低于之前预期的7.10美元至7.40美元，与分析师预期的平均0.67美元相符。施贵宝计划在明年裁减2200个工作岗位，以实现到2025年底减少15亿美元成本的目标。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/Y2U1MTljZjZkNTgxMTYyODU5MDU0MTEzOA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2U1MTljZjZkNTgxMTYyODU5MDU0MTEzOA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"275264","is_publish_highlight":false,"gpt_icon":0},{"id":"2430872286","title":"施贵宝盘中异动 早盘股价大跌5.08%报46.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430872286","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430872286?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:42","pubTimestamp":1714052521,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时42分，施贵宝股票出现异动，股价大幅下挫5.08%。施贵宝股票所在的制药行业中，整体跌幅为0.23%。因收购事项影响，百时美施贵宝下调今年盈利预期，该公司预计全年调整后的每股收益在0.40美元至0.70美元之间，远低于之前预期的7.10美元至7.40美元，与分析师预期的平均0.67美元相符。百时美施贵宝计划在明年裁减2200个工作岗位，以实现到2025年底减少15亿美元成本的目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214202861e90ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214202861e90ae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430286833","title":"百时美施贵宝Q1由盈转亏 大幅下调今年盈利预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286833","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430286833?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:17","pubTimestamp":1714051074,"startTime":"0","endTime":"0","summary":"百时美施贵宝公布2024年第一季度业绩，销售额为118.65亿美元，同比增长4.66%，市场预期为114.58亿美元；每股亏损为4.40美元，较上年同期的每股盈利2.05美元由盈转亏，市场预期为每股亏损4.44美元。因收购事项影响，百时美施贵宝下调今年盈利预期，该公司预计全年调整后的每股收益在0.40美元至0.70美元之间，远低于之前预期的7.10美元至7.40美元，与分析师预期的平均0.67美元相符。百时美施贵宝计划在明年裁减2200个工作岗位，以实现到2025年底减少15亿美元成本的目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252135498b5332d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252135498b5332d8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430406974","title":"BUZZ-交易成本影响 2024 年前景，百时美施贵宝业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2430406974","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430406974?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:27","pubTimestamp":1714044435,"startTime":"0","endTime":"0","summary":"    4月25日 - ** 制药商百时美施贵宝  股价盘前下跌1.5%至48.14美元 ** 由于交易费用，百时美施贵宝将其  年度利润预期下调至每股 40 美分至 70 美分，而之前的预期为每股 7.10 美元至 7.40 美元。** BMY 去年同期调整后每股收益为 2.05 美元。** BMY第一季度营收为118.7亿美元，高于分析师预期的114.8亿美元。** 抗癌药物 Opdivo 的销售额为 20.8 亿美元，比预期低 2400 万美元。** 截至上一交易日收盘，BMY 累计下跌约 5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430462500","title":"未来一天的看点 - 4月25日星期四","url":"https://stock-news.laohu8.com/highlight/detail?id=2430462500","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430462500?lang=zh_cn&edition=full","pubTime":"2024-04-25 02:30","pubTimestamp":1713983434,"startTime":"0","endTime":"0","summary":"美国劳工部的每周失业救济申请数据可能会显示，在截至4月20日的一周内，各州首次申请失业救济的人数增加了3000人，经季节性因素调整后为215000人。与此同时，首次领取失业救济金的人数可能从截至4月13日当周的181.2万人降至180.5万人。美国航空公司将公布第一季度财报。由于主要市场需求低迷，陶氏预计将公布第一季度收入下降的报告。烟草巨头 Altria 将公布第一季度业绩。受客户转向广告流媒体的帮助，Roku 第一季度收入预计将增长 14.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":-0.0192},{"period":"1month","weight":-0.157},{"period":"3month","weight":-0.0969},{"period":"6month","weight":-0.1672},{"period":"1year","weight":-0.3417},{"period":"ytd","weight":-0.1427}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月根据特拉华州法律注册成立，名为百时美公司，继承了1887年在纽约成立的一家企业。1989年，由于合并，公司更名为百时美施贵宝公司。公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。他们在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。 他们预计他们对Celgene和MyoKardia的收购将进一步将他们定位为领先的生物制药公司，通过多项近期资产和额外的外部合作伙伴扩大他们的肿瘤学、血液学、免疫学和心血管产品组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.013265},{"month":2,"riseRate":0.545455,"avgChangeRate":0.009113},{"month":3,"riseRate":0.636364,"avgChangeRate":0.008429},{"month":4,"riseRate":0.488889,"avgChangeRate":-0.002113},{"month":5,"riseRate":0.6,"avgChangeRate":0.005022},{"month":6,"riseRate":0.613636,"avgChangeRate":0.010539},{"month":7,"riseRate":0.409091,"avgChangeRate":-0.003649},{"month":8,"riseRate":0.5,"avgChangeRate":-0.004242},{"month":9,"riseRate":0.522727,"avgChangeRate":0.010569},{"month":10,"riseRate":0.568182,"avgChangeRate":0.024004},{"month":11,"riseRate":0.613636,"avgChangeRate":0.020382},{"month":12,"riseRate":0.636364,"avgChangeRate":0.022108}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}